|
Volumn 82, Issue 1, 2017, Pages 737-744
|
Alternate "drug" Delivery Utilizing β-Lactam Cores: Syntheses and Biological Evaluation of β-Lactams Bearing Isocyanate Precursors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIDES;
TARGETED DRUG DELIVERY;
BETA-LACTAMS;
BIOLOGICAL ASSESSMENT;
BIOLOGICAL EVALUATION;
REACTIVE SPECIES;
CONTROLLED DRUG DELIVERY;
4 METHOXYBENZYL 3 [(N HYDROXYBENZAMIDO)METHYL] 8 OXO 7 (2 PHENYLACETAMIDO) 5 THIA 1 AZABICYCLO[4.2.0]OCT 2 ENE 2 CARBOXYLIC ACID;
8 OXO 7 (2 PHENYLACETAMIDO) 3 [[N (TOSYLOXY)BENZAMIDO]METHYL] 5 THIA 1 AZABICYCLO[4.2.0]OCT 2 ENE 2 CARBOXYLIC ACID;
ANTIBIOTIC AGENT;
BETA LACTAM DERIVATIVE;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
ISOCYANATE;
MONOBACTAM DERIVATIVE;
UNCLASSIFIED DRUG;
BETA LACTAM;
ISOCYANIC ACID DERIVATIVE;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BIOLOGICAL ACTIVITY;
CHEMICAL REACTION;
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
DRUG DESIGN;
DRUG RELEASE;
DRUG SYNTHESIS;
HYDROLYSIS;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
STEREOCHEMISTRY;
STRUCTURE ACTIVITY RELATION;
CHEMICAL STRUCTURE;
CHEMISTRY;
SYNTHESIS;
BETA-LACTAMS;
DRUG DELIVERY SYSTEMS;
ISOCYANATES;
MOLECULAR STRUCTURE;
|
EID: 85018510723
PISSN: 00223263
EISSN: 15206904
Source Type: Journal
DOI: 10.1021/acs.joc.6b02272 Document Type: Article |
Times cited : (20)
|
References (25)
|